Dexcom (DXCM)
Dexcom stock today
Dexcom closed at $82.29 on October 30, 2026, up 2.95% on the day. Over the past year it returned +20.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $31.1 billion.
| Period | DXCM | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.6% | -0.9% |
| 3 months | +10.4% | +2.1% |
| Year to date | +24.0% | +11.7% |
| 1 year | +20.7% | +12.4% |
| 3 years | -3.1% | +88.5% |
| 5 years | -47.2% | +76.0% |
Key statistics
- Market value
- $31.1B
- P/E (trailing)
- 32.4
- Forward P/E
- 27.3
- Price / sales
- 6.1
- 52-week range
- $54.84 to $92.34
About Dexcom
Manufactures continuous glucose monitoring systems for diabetes management.
Sector: Health Care · Industry: Health Care Equipment
More on Dexcom
- Financials: revenue, earnings and segmentsRevenue +16% in the year to Dec 2025
- Valuation: P/E history and peersP/E 32.4, median 95.5 at its last 7 year ends
- Returns: what $1,000 became$1,000 ten years ago is $4,292 today
No forecast, no recommendation. This page describes Dexcom from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.